Skip to content
ClinCalc Pro
Menu
Local Anaesthetic (Amide)

Prilocaine

Brand names: Citanest, EMLA (with lidocaine)

Prilocaine is an amide local anaesthetic used for infiltration, regional and intravenous regional anaesthesia, and as a topical agent in combination preparations.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It reversibly blocks voltage-gated sodium channels in nerve membranes, preventing depolarisation and the propagation of action potentials.

Prescribing in practice

  • Excessive doses can cause methaemoglobinaemia through a metabolite, so it is used with particular caution in those susceptible, and methylthioninium chloride is the treatment for significant methaemoglobinaemia.
  • As with all local anaesthetics, inadvertent intravascular injection or overdose can cause systemic central nervous system and cardiac toxicity.
  • It is often regarded as relatively favourable for intravenous regional anaesthesia, but the maximum safe dose must always be calculated for the individual patient.

Monitoring

Monitor for signs of local anaesthetic systemic toxicity and for cyanosis or low oxygen saturations suggesting methaemoglobinaemia.

Counselling the patient

  • Report dizziness, perioral tingling, ringing in the ears or a metallic taste, which can be early signs of toxicity.
  • Bluish discolouration of the lips or skin should be reported immediately.

Evidence & guidelines

Its association with methaemoglobinaemia and its use in regional anaesthesia are well documented in standard anaesthetic references and the SPC.

Reference: AAGBI IV Regional Anaesthesia Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.